C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
195/1.2, 195/1.3
C12N 15/57 (2006.01) C07K 14/755 (2006.01) C12N 9/64 (2006.01) C12N 15/62 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1340512
Methods are disclosed for producing proteins having biological activity for blood coagulation mediated by Factor VIIa or Factor IX. The proteins are produced by mammalian host cells which have been stably transfected with a DNA construct containing a nucleotide sequence which codes at least partially for either Factor VII or Factor IX. The nucleotide sequence comprises a first nucleotide sequence encoding a calcium binding domain, joined to a second nucleotide sequence positionned downstream of the first sequence. In particular, the first nucleotide sequence may be derived from a genomic clone or cDNA clone of Factor VII. The second sequence encodes a catalytic domain for the serine protease activity of either Factor VIIA or Factor IX. The joined sequences code for proteins having substantially the same biological activity for blood coagulation as either Factor VIIa or Factor IX.
506908
Berkner Kathleen L.
Busby Sharon J.
Gray Charles L.
Hagen Frederick S.
Insley Margaret Y.
Mccarthy Tetrault Llp
Novo Nordisk Health Care Ag
Zymogenetics Inc.
LandOfFree
Expression of factor vii and ix activities in mammalian cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression of factor vii and ix activities in mammalian cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression of factor vii and ix activities in mammalian cells will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1181396